Guillermo Bastida
Overview
Explore the profile of Guillermo Bastida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
728
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ricart E, Bastida G, Carpio D, Ceballos D, Ginard D, Marin-Jimenez I, et al.
Crohns Colitis 360
. 2024 Oct;
6(4):otae055.
PMID: 39445340
Background: We aimed to (1) analyze the applicability of the updated Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) recommendations in real-world clinical practice, (2) identify barriers to their implementation,...
2.
Minguez A, Coello E, Garrido A, Ripoll P, Gomez M, Aguas M, et al.
Gastroenterol Hepatol
. 2024 Sep;
:502253.
PMID: 39270973
Background And Aims: Ustekinumab is an effective treatment for inflammatory bowel diseases. However, some patients do not respond to conventional doses. The aim of the study was to evaluate the...
3.
Casanova M, Caballol B, Garcia M, Mesonero F, Rubin de Celix C, Suarez-Alvarez P, et al.
Dig Liver Dis
. 2024 Jun;
56(11):1845-1853.
PMID: 38839456
Background: The efficacy of ustekinumab and vedolizumab for treating complex perianal fistula in Crohn's disease has been barely studied. We aimed to assess treatment persistence, clinical remission, and safety of...
4.
Plaza J, Minguez A, Bastida G, Marques R, Nos P, Poveda J, et al.
Int J Mol Sci
. 2024 Apr;
25(7).
PMID: 38612528
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the digestive tract usually characterized by diarrhea, rectal bleeding, and abdominal pain. IBD includes Crohn's disease and ulcerative colitis as...
5.
Gonzalez-Lama Y, Ricart E, Carpio D, Bastida G, Ceballos D, Ginard D, et al.
BMJ Open Gastroenterol
. 2024 Jan;
11(1).
PMID: 38267072
Background: Despite research, there are still controversial areas in the management of Crohn's disease (CD). Objective: To establish practical recommendations on using anti-tumour necrosis factor (TNF) drugs in patients with...
6.
Bastida G, Alvarez-Sotomayor D, Aguas M, Iborra M, Del Hoyo J, Bejar-Serrano S, et al.
Gastroenterol Hepatol
. 2023 Dec;
47(5):473-480.
PMID: 38072359
Background: Thiopurines such as azathioprine (AZA) and mercaptopurine (MP) are commonly utilized to treat inflammatory bowel disease (IBD). Their use is frequently restricted due to gastrointestinal intolerance (GI). Previous retrospective...
7.
Saez-Gonzalez E, Moret-Tatay I, Bastida G, Aguas M, Iborra M, Nos P, et al.
J Clin Apher
. 2023 Dec;
39(1):e22101.
PMID: 38054256
Background: Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic inflammation of the gastrointestinal tract, affecting millions of individuals throughout the world, and producing an impaired health-related quality...
8.
Iborra M, Ferreiro-Iglesias R, Maria Dolores M, Mesonero Gismero F, Minguez A, Porto-Silva S, et al.
Scand J Gastroenterol
. 2023 Nov;
59(3):260-268.
PMID: 37933161
Objective: Ustekinumab was recently approved for the treatment of moderate-to-severe ulcerative colitis (UC). Although data from the UNIFI clinical trial are encouraging, real-world data assessing effectiveness and safety are scarce....
9.
Bastida G, Minguez A, Nos P, Moret-Tatay I
Genes (Basel)
. 2023 Mar;
14(3).
PMID: 36980826
The immune system and environmental factors are involved in various diseases, such as inflammatory bowel disease (IBD), through their effect on genetics, which modulates immune cells. IBD encompasses two main...
10.
Riestra S, Taxonera C, Zabana Y, Carpio D, Chaparro M, Barrio J, et al.
J Clin Med
. 2022 Jul;
11(13).
PMID: 35807201
(1) Aims: Patients receiving antitumor necrosis factor (anti-TNF) therapy are at risk of developing tuberculosis (TB), usually due to the reactivation of a latent TB infection (LTBI). LTBI screening and...